Conmed (CNMD) Stock Statistics & Valuation Metrics

Conmed has a market cap or net worth of $1.36B. The enterprise value is $2.19B.

Conmed has 30,833,536 shares outstanding. The number of shares has decreased by -2.65% in one year.

Conmed’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.28%.

The current PE Ratio of Conmed is 29.3. Conmed’s PEG ratio is -0.41.

In the last 12 months, Conmed had revenue of 1.37B and earned 47.05M in profits. Earnings per share was 1.52.

In the last 12 months, operating cash flow was 170.69M and capital expenditures -19.81M, giving a free cash flow of 150.88M billion.

Conmed pays an annual dividend of $0.2, resulting in a dividend yield of 2.02%

Conmed upcoming earnings date is May 6, 2026, After Close (Confirmed).

Conmed as a current ratio of 2.14, with Debt / Equity ratio of 80.82%

In the past 12 months, Conmed has paid 24.06M in taxes.

Conmed EV to EBITDA ratio is 11.62, with an EV/FCF ratio of 13.61.

Conmed has $40.82M in cash and marketable securities with $834.94M in debt, giving a net cash position of -$794.13M billion.

Gross margin is 53.87%, with operating margin of 9.47%, and net profit margin of 3.42%.

The average price target for Conmed is $49.67, which is 11.43% higher than the current price. The consensus rating is Hold